Reported value$3.0M12,200 shares at $245.99
For this personVery unusual1 buy · 6 sales on file
Similar buys beat S&P43%90 cases · all buys 46%
Worth a closer look
- Open-market purchase with their own money (Form 4 code P), not a grant or option exercise.
- Bought by the CEO, one of the two people with the fullest view of the company.
- Raised their own holding by 46%.
- Their first purchase here in our data, after 6 sales.
Reasons for caution
- Other insiders sold $3.8M in the same 90 days, more than was bought (62% of it pre-planned).
- Similar past buys beat the S&P 500 only 43% of the time (90 cases); the typical one trailed it by 1.8%.
What happened after this filing
7 days
Pending
due Nov 4
30 days
Pending
due Nov 27
90 days
Pending
due Jan 26
Insider Twins: past buys with the same traits
2 insiders buying · incl. CEO or CFO · $1M+ · stock up over 3 months
PLSE May 15, 2026 +77.5% vs S&PRILY Nov 5, 2020 +61.6% vs S&PHROW Mar 28, 2024 +56.7% vs S&PCNTM Jun 23, 2026 -52.6% vs S&PANVS Nov 25, 2025 -51.8% vs S&PCMCO Nov 15, 2024 -49.1% vs S&PWhat we couldn't check
- Why they traded. Filings don't say, and we don't guess.
- Company news after the filing, and any private terms.
Summary
Julie Spellman Sweet (CEO) bought $3.0M of ACN at about $245.99 on Oct 26, 2026, reported to the SEC on Oct 28, 2026. Buys like this beat the S&P 500 43% of the time since 2020, against 46% for all insider buys. We found 4 points that make it worth a closer look and 2 reasons for caution. History, not a prediction.
Following. We'll keep this page updated; see everything you follow. Want an email when the 30 and 90-day results land? Use the ACN alerts below.
Written by fixed rules from SEC filings and our measured history, not by an AI model. Public data only. History, not a prediction, and not investment advice.